An Extended Cost-Effectiveness Analysis of Publicly Financed HPV Vaccination to Prevent Cervical Cancer in China
Authors: Carol Levin, Monisha Sharma, Zach Olson, Stéphane Verguet, Ju-Fang Shi, Shao Ming Wang, You-Lin Qiao, Dean Jamison, Jane J. Kim
Cervical cancer screening and existing health insurance schemes in China fall short of reaching women with preventative and treatment services, especially women in rural areas, where the burden of disease is greatest. An extended cost-effectiveness analysis evaluated the impact of a publically financed HPV vaccination program on equity and financial risk protection. HPV vaccination reduced cervical cancer by 44 percent overall and provided higher financial protection to the poorest women.